Fintepla

Fenfluramine Hydrochloride, marketed as Fintepla, is a prescription medication used to manage seizures associated with Dravet syndrome. This oral medication is designed to help control seizures in patients with this rare form of epilepsy.

Fenfluramine Hydrochloride is primarily used for the treatment of seizures in patients with Dravet syndrome, a severe form of epilepsy. This medication works by affecting certain chemicals in the brain that may be involved in causing seizures. It is important to use this medication exactly as prescribed by a healthcare provider.

Common effects of Fenfluramine Hydrochloride may include decreased appetite, fatigue, and drowsiness. Some users may also experience irritability or changes in mood. It is important to monitor for any unusual side effects and consult a healthcare provider if they occur.

Fenfluramine Hydrochloride should be used with caution in patients with a history of heart problems or high blood pressure. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. This medication should be stored at room temperature and kept out of reach of children.

Fenfluramine Hydrochloride may interact with other medications, including those that affect the central nervous system. It is important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.